Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
Clinical trial NCT01434602 · COMPLETED
Trial details
- NCT number
- NCT01434602
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-02
- Primary completion
- 2020-10-19
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.